Last 7 days
2.4%
Last 30 days
15.1%
Last 90 days
12.5%
Trailing 12 Months
-34.8%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 76.7M | 80.2M | 81.6M | 0 |
2022 | 54.1M | 56.4M | 58.7M | 60.9M |
2021 | 13.0M | 25.9M | 38.9M | 51.8M |
2020 | 0 | 0 | 0 | 24.0K |
2019 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 20, 2023 | bellon christine | sold | -305,000 | 30.5 | -10,000 | chief legal officer |
Nov 20, 2023 | bellon christine | acquired | 72,200 | 7.22 | 10,000 | chief legal officer |
Oct 30, 2023 | simon amy | sold | -64,477 | 18.7 | -3,448 | chief medical officer |
Oct 20, 2023 | ciaramella giuseppe | acquired | 60,903 | 0.67 | 90,900 | president and cso |
Oct 02, 2023 | bellon christine | sold | -8,865 | 22.85 | -388 | chief legal officer |
Jul 24, 2023 | ciaramella giuseppe | sold | -38,604 | 32.01 | -1,206 | president and cso |
Jul 24, 2023 | ciaramella giuseppe | acquired | 8,707 | 7.22 | 1,206 | president and cso |
Jul 21, 2023 | ciaramella giuseppe | sold | -4,979,690 | 32.06 | -155,324 | president and cso |
Jul 21, 2023 | ciaramella giuseppe | acquired | 659,070 | 7.22 | 91,284 | president and cso |
Jul 10, 2023 | simon amy | sold | -11,917 | 30.48 | -391 | chief medical officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | CITIGROUP INC | added | 21.48 | -441,334 | 4,752,210 | -% |
Nov 27, 2023 | AllSquare Wealth Management LLC | reduced | -78.57 | -14,978 | 2,886 | -% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 8.36 | -307,690 | 1,366,020 | -% |
Nov 21, 2023 | COMERICA BANK | new | - | 12,939 | 12,939 | -% |
Nov 16, 2023 | Financial Gravity Asset Management, Inc. | sold off | -100 | -31.00 | - | -% |
Nov 15, 2023 | GSA CAPITAL PARTNERS LLP | new | - | 283,000 | 283,000 | 0.02% |
Nov 15, 2023 | MORGAN STANLEY | reduced | -37.48 | -14,110,500 | 12,557,200 | -% |
Nov 15, 2023 | Beaird Harris Wealth Management, LLC | reduced | -49.76 | -4,188 | 2,550 | -% |
Nov 15, 2023 | Baker Avenue Asset Management, LP | added | 26.09 | -37.00 | 697 | -% |
Nov 15, 2023 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | added | 22.29 | -69,070 | 806,036 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 22, 2023 | farallon capital partners, l.p. | 0.4% | 306,547 | SC 13G | |
Mar 17, 2023 | temasek holdings (private) ltd | 5.0% | 3,644,573 | SC 13G | |
Feb 14, 2023 | farallon capital partners, l.p. | 0.0% | 0 | SC 13G/A | |
Feb 10, 2023 | temasek holdings (private) ltd | 4.1% | 2,878,297 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.90% | 6,273,630 | SC 13G/A | |
Feb 02, 2023 | blackrock inc. | 7.4% | 5,238,280 | SC 13G/A | |
Jul 14, 2022 | farallon capital partners, l.p. | 0.4% | 276,948 | SC 13G | |
Feb 14, 2022 | arch venture fund ix, l.p. | 8.6% | 5,843,039 | SC 13G/A | |
Feb 14, 2022 | redmile group, llc | 2.8% | 1,885,850 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 22, 2023 | 4 | Insider Trading | |
Nov 20, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 08, 2023 | 8-K | Current Report | |
Nov 08, 2023 | 10-Q | Quarterly Report | |
Nov 01, 2023 | 4 | Insider Trading | |
Oct 31, 2023 | 8-K | Current Report | |
Oct 30, 2023 | 144 | Notice of Insider Sale Intent | |
Oct 24, 2023 | 4 | Insider Trading | |
Oct 19, 2023 | 8-K | Current Report | |
Oct 12, 2023 | UPLOAD | UPLOAD |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HILS | 31.5B | - | 5.25% | 401813.88% | -3.7K | 218.4K | - | -102.45% |
MRNA | 30.6B | 10.7B | 8.54% | -55.34% | -8.83 | 2.87 | -53.67% | -129.46% |
ALNY | 21.3B | 1.7B | 4.15% | -23.37% | -41.84 | 12.38 | 79.37% | 56.87% |
BMRN | 17.5B | 2.3B | 11.05% | -8.44% | 119.09 | 7.58 | 15.05% | 75.21% |
INCY | 12.3B | 3.6B | 0.84% | -34.33% | 28.84 | 3.4 | 8.35% | -51.49% |
MID-CAP | ||||||||
APLS | 7.4B | 272.9M | 35.37% | 34.74% | -12.26 | 27.23 | 141.38% | 4.43% |
BBIO | 5.7B | - | 14.36% | 263.35% | -9.69 | 48.33 | 54.84% | -12.96% |
ACAD | 3.4B | 631.9M | -7.32% | 48.57% | -23.12 | 5.44 | 23.54% | 31.53% |
AXSM | 3.3B | 223.4M | 11.28% | -10.13% | -16.45 | 14.86 | - | -26.24% |
ARWR | 2.6B | 240.7M | -10.83% | -25.35% | -12.52 | 10.67 | -1.03% | -16.59% |
SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 11.36% | -14.92% | 24.33 | 4.33 | 81.69% | -7.29% |
NVAX | 661.3M | 1.0B | -22.00% | -67.89% | -1.2 | 0.63 | -43.15% | 58.48% |
INO | 100.5M | 6.4M | - | -79.23% | -0.61 | 15.6 | -44.11% | 50.48% |
IBIO | 37.6M | - | 376.67% | 112.17% | -0.58 | - | - | -29.23% |
CRBP | 23.7M | - | 25.24% | 3980.68% | -0.5 | - | - | -13.74% |
Income Statement (Quarterly) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -14.5% | 17,193,000 | 20,116,000 | 24,208,000 | 20,037,000 | 15,799,000 | 16,652,000 | 8,432,000 | 6,325,500 | 4,219,000 | 2,112,500 | 6,000 | 6,000 | 6,000 | 162,800 | 319,600 | 476,400 | 633,200 | 790,000 | 498,000 |
Operating Expenses | 2.6% | 125,460,000 | 122,264,000 | 123,136,000 | 109,022,000 | 107,102,000 | 98,618,000 | 84,657,000 | 114,553,000 | 70,397,000 | 58,980,000 | 200,379,000 | 40,805,000 | 37,327,000 | 26,291,000 | 28,361,000 | 26,377,000 | 18,030,000 | 17,657,000 | 13,108,000 |
S&GA Expenses | 3.1% | 25,410,000 | 24,656,000 | 23,490,000 | 22,681,000 | 21,815,000 | 24,062,000 | 19,247,000 | 17,772,000 | 15,774,000 | 13,403,000 | 10,273,000 | 8,354,000 | 7,502,000 | 6,937,000 | 6,812,000 | 6,160,000 | 5,487,000 | 4,977,000 | 3,929,000 |
R&D Expenses | 2.5% | 100,050,000 | 97,608,000 | 99,646,000 | 86,341,000 | 85,287,000 | 74,556,000 | 65,410,000 | 96,781,000 | 54,623,000 | 45,577,000 | 190,106,000 | 32,451,000 | 29,825,000 | 19,354,000 | 21,549,000 | 20,217,000 | 12,543,000 | 12,680,000 | 9,179,000 |
EBITDA Margin | - | - | - | -3.19 | -4.03 | -4.77 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | -44.0% | 28,000 | 50,000 | 62,000 | 76,000 | 86,000 | 101,000 | 113,000 | 124,000 | 136,000 | 148,000 | 159,000 | 139,000 | 140,000 | - | - | - | - | - | - |
Income Taxes | - | - | - | - | 1,010,000 | 2,410,000 | - | - | - | - | - | 159,000 | -422,000 | 140,000 | 148,000 | 134,000 | - | - | - | - |
Earnings Before Taxes | - | - | - | - | -37,349,000 | -81,665,000 | - | - | -64,707,000 | -28,118,000 | - | - | - | - | - | - | - | - | - | - |
EBT Margin | - | - | - | -3.39 | -4.27 | -4.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -16.1% | -96,088,000 | -82,776,000 | -96,460,000 | -38,349,000 | -109,575,000 | -71,950,000 | -69,214,000 | -64,707,000 | -28,118,000 | -76,253,000 | -201,560,000 | -95,464,000 | -34,452,000 | -34,218,000 | -30,458,000 | -27,850,000 | -19,005,000 | -17,861,000 | -13,610,000 |
Net Income Margin | 100.0% | - | -4.08 | -4.12 | -4.75 | -5.38 | -4.51 | -4.60 | -7.15 | -10.32 | -15.72 | -28.18 | -8,108 | -282 | -127 | -73.21 | - | - | - | - |
Free Cashflow | 100.0% | - | -100,847,000 | -115,832,000 | -77,452,000 | -86,283,000 | -73,920,000 | 211,231,000 | -11,539,000 | -2,773,000 | -48,711,000 | -50,056,000 | -32,423,000 | -24,032,000 | -25,204,000 | -30,439,000 | -19,960,000 | -18,411,000 | - | - |
Balance Sheet | (In Millions) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Assets | -4.7% | 1,291 | 1,354 | 1,332 | 1,342 | 1,350 | 1,418 | 1,453 | 1,474 | 1,157 | 893 | 693 | 452 | 278 | 300 | 323 | 156 |
Current Assets | -5.0% | 1,040 | 1,095 | 1,083 | 1,093 | 1,109 | 1,180 | 1,239 | 1,273 | 941 | 678 | 515 | 308 | 209 | 235 | 260 | 95.00 |
Cash Equivalents | -21.2% | 178 | 226 | 250 | 233 | 157 | 266 | 297 | 573 | 612 | 212 | 97.00 | 162 | 138 | 125 | 126 | 51.00 |
Net PPE | -0.5% | 128 | 128 | 122 | 116 | 111 | 106 | 94.00 | 84.00 | 72.00 | 64.00 | 52.00 | 39.00 | 29.00 | 26.00 | 25.00 | 24.00 |
Liabilities | -5.7% | 512 | 542 | 571 | 608 | 636 | 618 | 624 | 648 | 303 | 345 | 271 | 206 | 78.00 | 69.00 | 61.00 | 55.00 |
Current Liabilities | 5.2% | 220 | 210 | 220 | 224 | 239 | 212 | 219 | 213 | 101 | 129 | 102 | 102 | 47.00 | 39.00 | 31.00 | 29.00 |
Shareholder's Equity | -4.0% | 779 | 812 | 762 | 733 | 714 | 800 | 829 | 827 | 854 | 549 | 422 | 246 | 200 | 231 | 261 | - |
Retained Earnings | -8.3% | -1,300 | -1,200 | -1,153 | -1,057 | -1,019 | -909 | -837 | -768 | -703 | -675 | -599 | -397 | -302 | -267 | -233 | -203 |
Additional Paid-In Capital | 3.1% | 2,113 | 2,049 | 1,915 | 1,793 | 1,737 | 1,713 | 1,669 | 1,594 | 1,557 | 1,223 | 1,021 | 643 | 502 | 498 | 495 | 2.00 |
Shares Outstanding | 1.8% | 79.00 | 78.00 | 74.00 | 71.00 | 70.00 | 70.00 | 69.00 | 68.00 | 66.00 | 62.00 | 60.00 | 57.00 | 50.00 | 49.00 | 31.00 | 7.00 |
Cashflow (Quarterly) | (In Millions) | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -6.0% | -89.78 | -84.67 | -109 | -69.19 | -74.50 | -52.28 | 218 | 2.00 | 3.00 | -32.53 | -38.58 | -24.30 | -21.21 | -22.84 | -27.39 | -17.80 | -16.99 | -11.35 | -25.86 |
Share Based Compensation | -1.7% | 26.00 | 26.00 | 24.00 | 22.00 | 22.00 | 22.00 | 18.00 | 16.00 | 13.00 | 10.00 | 5.00 | 7.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 1.00 |
Cashflow From Investing | 75.3% | -10.23 | -41.48 | 25.00 | 113 | -36.17 | -1.26 | -537 | -77.50 | 76.00 | -13.14 | -279 | -81.43 | 35.00 | 23.00 | -76.79 | 17.00 | 14.00 | -95.08 | -2.35 |
Cashflow From Financing | -65.8% | 37.00 | 108 | 98.00 | 32.00 | 2.00 | 22.00 | 56.00 | 22.00 | 321 | 160 | 253 | 130 | 0.00 | -0.78 | 193 | 1.00 | 3.00 | -0.02 | 38.00 |
Condensed Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
License and collaboration revenue | $ 17,193,000 | $ 15,799,000 | $ 61,517,000 | $ 40,883,000 |
Revenue, Product and Service [Extensible List] | us-gaap:LicenseMember | us-gaap:LicenseMember | us-gaap:LicenseMember | us-gaap:LicenseMember |
Operating expenses: | ||||
Research and development | $ 100,050,000 | $ 85,287,000 | $ 297,304,000 | $ 225,253,000 |
General and administrative | 25,410,000 | 21,815,000 | 73,556,000 | 65,124,000 |
Total operating expenses | 125,460,000 | 107,102,000 | 370,860,000 | 290,377,000 |
Loss from operations | (108,267,000) | (91,303,000) | (309,343,000) | (249,494,000) |
Other income (expense): | ||||
Change in fair value of derivative liabilities | 4,700,000 | (4,900,000) | 9,400,000 | 20,900,000 |
Change in fair value of non-controlling equity investments | (11,221,000) | 10,431,000 | (17,870,000) | (1,378,000) |
Change in fair value of contingent consideration liabilities | 6,002,000 | (875,000) | 7,877,000 | (543,000) |
Interest and other income (expense), net | 12,698,000 | 4,982,000 | 34,612,000 | 7,686,000 |
Total other income (expense) | 12,179,000 | 9,638,000 | 34,019,000 | 26,665,000 |
Net loss before income taxes | (96,088,000) | (81,665,000) | (275,324,000) | (222,829,000) |
Provision for income taxes | 0 | (2,410,000) | 0 | (2,410,000) |
Loss from equity method investment | (25,500,000) | (25,500,000) | ||
Net loss | (96,088,000) | (109,575,000) | (275,324,000) | (250,739,000) |
Unrealized gain (loss) on marketable securities | (9,000) | (484,000) | 406,000 | (4,624,000) |
Comprehensive loss | $ (96,097,000) | $ (110,059,000) | $ (274,918,000) | $ (255,363,000) |
Net loss per common share, basic | $ (1.22) | $ (1.56) | $ (3.63) | $ (3.59) |
Net loss per common share, diluted | $ (1.22) | $ (1.56) | $ (3.63) | $ (3.59) |
Weighted - average common shares outstanding, basic | 79,024,647 | 70,343,196 | 75,902,612 | 69,758,434 |
Weighted - average common shares outstanding, diluted | 79,024,647 | 70,343,196 | 75,902,612 | 69,758,434 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 169,049 | $ 232,767 |
Marketable securities | 846,408 | 845,367 |
Prepaid expenses and other current assets | 24,084 | 14,762 |
Total current assets | 1,039,541 | 1,092,896 |
Property and equipment, net | 127,521 | 115,620 |
Restricted cash | 8,680 | 12,754 |
Operating lease right-of-use assets | 112,140 | 118,513 |
Other assets | 2,652 | 1,931 |
Total assets | 1,290,534 | 1,341,714 |
Current liabilities: | ||
Accounts payable | 3,177 | 9,029 |
Accrued expenses and other current liabilities | 41,769 | 48,059 |
Derivative liabilities | 8,900 | 18,300 |
Current portion of deferred revenue | 153,484 | 135,974 |
Current portion of lease liability | 11,951 | 10,380 |
Current portion of equipment financing liability | 1,084 | 1,853 |
Total current liabilities | 220,365 | 223,595 |
Long-term lease liability | 160,637 | 168,625 |
Long-term equipment financing liability | 304 | 1,154 |
Contingent consideration liabilities | 4,586 | 12,463 |
Long-term portion of deferred revenue | 124,653 | 202,179 |
Other liabilities | 1,048 | 224 |
Total liabilities | 511,593 | 608,240 |
Commitments and contingencies (See Note 7, License agreements and Note 8, Collaboration and license agreements) | ||
Stockholders’ equity: | ||
Preferred stock, $0.01 par value; 25,000,000 shares authorized, and no shares issued or outstanding at September 30, 2023 and December 31, 2022, respectively | ||
Common stock, $0.01 par value; 250,000,000 shares authorized, 79,382,032 and 71,277,339 issued and outstanding at September 30, 2023 and December 31, 2022, respectively | 794 | 712 |
Additional paid-in capital | 2,112,857 | 1,792,554 |
Accumulated other comprehensive (loss) income | (2,024) | (2,430) |
Accumulated deficit | (1,332,686) | (1,057,362) |
Total stockholders' equity | 778,941 | 733,474 |
Total liabilities and stockholders' equity | $ 1,290,534 | $ 1,341,714 |
 CEO | Mr. John M. Evans M.B.A. |
---|---|
 WEBSITE | beamtx.com |
 EMPLOYEES | 532 |